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31.Background
 15,000 deaths in less than a year;
 Severe cases in healthy young people (90% of all 
deaths occurred in those younger than 65 years).
Influenza A(H1N1)pdm09:
4Portugal
 64% of the laboratory-confirmed cases for the influenza A(H1N1)pdm09
virus were detected in the age group of 5–14 years old;
 A total of 1436 hospitalizations were reported;
 the estimated mortality rate was 1.17 per 100000 inhabitants,
corresponding to 124 laboratory confirmed influenza deaths.
According to the Portuguese
Influenza Surveillance Program
(NISP):
1. Background
5 Virus pathogenicity
 Host genetic susceptibility
Why do some individuals resist to infection or recover 
quickly, whereas others experience severe disease 
associated with the infection?
WHO (2009): 
identified studies of the host 
genetic factors’ role on 
susceptibility
to severe influenza as a 
priority.
https://www.flickr.com/photos/ibm_research_zurich/7250979508/
Intensive research 
?
1. Background
6 They found a higher frequency of a minor
IFITM3 allele (SNP rs12252-C) in
hospitalized subjects with Influenza infection
in comparison with the European 1000
genomes subjects.
Everitt et al, 2012
 IFITM3 alters the course of influenza virus
infection (animal models);
1. Background
7To estimate the association between the IFITM3 
rs12252 variant (C allele) and the risk of hospitalization
due to respiratory illness in Portuguese patients with 
influenza A(H1N1)pdm09 infection
2.Objetive
3. Methods
3.1. Study design and participants
 Case-control genetic association study;
 Comparison of the allele frequency between hospitalized influenza-like
illness (ILI) patients (cases) vs non hospitalized ILI patients (controls);
 Nasopharyngeal/oropharyngeal swabs received at INSA for diagnostic
purposes from the Portuguese Laboratory Network for the Diagnosis of
Influenza Infection (between 09/2009 and 02/2010)
8Exclusion criteria: 
1. Patients over 65 years old; 
2. Immunodepressed or transplanted patients;
3. Patients with chronic diseases (diabetes, lung, kidney, cardiovascular, liver, 
neurological, immunologic and oncologic diseases); 
4. Pregnant women; 
5. Notification data before the mitigation phase (01-09-2009); 
6. Patients for whom the time lapse between the symptoms onset and the 
sample collection was over 7 days;
7. Samples with unavailable information about hospitalization; 
8. Samples with unavailable laboratorial result for A(H1N1)pdm09 virus; 
9. Samples stored outside of the INSA.
3. Methods
9Cases and controls selection (1 case: 2 paired controls)
 Hospitalization: measure of disease severity (defined as a hospital
admission due to ILI complications with a concomitant hospital stay
for more than 24 hours).
3. Methods
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Genotyping:
 DNA extraction: automatic system (MagNA Pure LC—Roche); 
 Genotyping: RFLP (restriction fragment length polymorphism).
Statistical analysis:
 R program;
 Stratified analysis by ILI A(H1N1)pdm09 positive and negative patients;
 Conditional Logistic Regression for matched Pairs Data including the
potential confounding effect of age and gender variables was used to
estimate adjusted Odds-Ratio.
3. Methods
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4. Results
 ILI A(H1N1)pdm09 positive patients ILI A(H1N1)pdm09 negative patients p 
 
Hospitalized 
(cases) 
Non-hospitalized 
(controls) 
Hospitalized 
(cases) 
Non-hospitalized 
(controls) 
 
n 96 212 198 403 - 
Genotyped samples 
(%) 
84 
(87.5%) 
184 
(86.8%) 
173 
(84.4%) 
351 
(87.1%) 
 
0.9981 
1p-values were obtained by the Pearson's chi-squared test. 
 From the 936 patients selected, 909 had sufficient available frozen 
swabs for DNA extraction;
 The overall success rate was 87% and it was similar in all the 4 
groups of patients (p = 0.998).
Table S1- Genotyping success rates in each ILI patients group.
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4. Results
 No significant differences were found regarding age and sex.
Table 1. Patients characterization, regarding the age and gender variables.
 ILI A(H1N1)pdm09 positive patients ILI A(H1N1)pdm09 negative patients 
 Hospitalized 
(cases) 
Non-hospitalized 
(controls) 
p Hospitalized 
(cases) 
Non-hospitalized 
(controls) 
p 
Age (years) 
Mean ± sd 
Median (range)  
 
16.6 ± 17.6 
10 (0-60) 
 
14.0 ± 12.4 
9 (0-54) 
 
0.8151 
 
15.7 ± 20.2 
4 (0-64) 
 
13.5 ± 16.1 
6 (0-62) 
 
0.3821 
Gender  
% of women  
(95% CI) 
 
40.5 
(30.0-51.0) 
 
46.2 
(39.0-53.4) 
 
0.3822 
 
43.9 
(36.5-51.3) 
 
47.3 
(42.1-52.5) 
 
0.4682 
1 p-values were obtained by the Wilcoxon test. 2 p-values were obtained by the Pearson's chi-squared test. (CI, Confidence interval;  
13
ILI A(H1N1)pdm09 positive patients ILI A(H1N1)pdm09 negative patients
Hospitalized
(cases)
Non-hospitalized
(controls)
OR 
Crude
(95% CI)
OR
Adjusted
(95% CI)
Hospitalized
(cases)
Non-hospitalized
(controls)
OR 
Crude
(95% CI)
OR
Adjusted
(95% CI)
n 84 184 - - 173 351 - -
IFITM3_rs12252
Genotypes 
TT (%)
CT (%)
CC (%) 
73 (86.9)
9 (10.7)
2 (2.4)
152 (82.6)
32 (17.4)
0 (0)
- - 134 (77.5)
39 (22.5)
0 (0)
312 (88.9)
38 (10.8)
1 (0.28)
- -
Alleles
C (%)
T (%)
13 (7.7)
155 (92.3)
32 (8.7)
336 (91.3)
- - 39 (11.3)
207 (92.3)
40 (5.7)
662 (94.3)
- -
Dominant model1
CT/CC (%)
vs
TT (%)
11 (13.1)
73 (86.9)
32 (17.4)
152 (82.6)
0.72
(0.34-1.50)
0.732
(0.33-1.50)
39 (22.5)
134 (77.5)
39 (11.1)
312 (88.9)
2.33
(1.43-3.79)
2.542
(1.54-4.19)
Table 2. IFITM3 rs12252 genotypic and allelic frequencies its association with 
hospitalization, assuming a dominant model.
 In patients negative for A(H1N1)pdm09 virus, the risk of being hospitalized
among the CT/CC genotype carriers is significantly higher than the risk of being
hospitalized in the TT genotype carriers.
4. Results
1 Other genetic models were not considered due the low frequency of CC genotype and the existence of zero patients with CC genotypes in
2 groups. 2Adjustment for age and gender by logistic regression.
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5. Discussion and Future Perspectives
 IFITM3 rs12252-C is involved in the ILI symptoms severity
associated with other respiratory infections (Influenza negative
samples could be positive for other respiratory virus);
 The future detection of other respiratory virus in the analyzed
samples would be important to clarify our results.
15
 Similar % of C allele carriers between Everitt el al. 2012  and the Influenza 
A(H1N1)pdm09 hospitalized positive cases (13.2% vs 13.1%). 
 % of C allele carriers in the Portuguese population (INSEF pilot study, 
n=193)  was 7.8%. 
5. Discussion and Future Perspetives
16
Limitations:
 Use of Hospitalization as a measure of the infection severity (Less severe
cases might have been hospitalized due to the initial pandemic alert):
this bias was reduced by excluding patients with disease onset reported
in the contention phase;
 Confounding adjustment only for age and sex variables in the logistic
regression analysis: the possible confounding bias was reduced by the
exclusion criteria used in the patients selection;
 Sample size limitation due to the low C allele frequency.
5. Discussion and Future Perspetives
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 To perform a future integrative approach to clarify why some healthy 
individuals resist infection or recover quickly, others experience 
severe disease associated with the influenza infection. 
5. Discussion and Future Perspetives
Considering not only the virus-host genome interactions but 
also immunity, vaccination, weather conditions and other 
environmental factors that could help to clarify the present 
results.
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